39 results about "Tracheal bronchus" patented technology

A method for controlling breathing gas flow of a ventilator for assisted or controlled ventilation of a patient as a function of a tracheobronchial airway pressure of the patient. A ventilator tube, such as a tracheal tube or tracheostomy tube, can be introduced into a trachea of the patient and subjected to the breathing gas, and has an inflatable cuff and at least one lumen that is continuous from a distal end of the tube to a proximal end of the tube. An apparatus detects an airway pressure, in which the tracheobronchial airway pressure is ascertained by continuous or intermittent detection and evaluation of an intra-cuff pressure prevailing in the cuff of the tube inserted into the trachea. The breathing gas flow of the ventilator is controlled as a function of the intra-cuff pressure detected.

BACKGROUND: Tracheotomy is used to assist patients who require mechanical ventilation. Tracheostomy is a common surgical procedure for intensive care patients. The goals of tracheotomy are to bypass the upper airway, facilitate removal of tracheobronchial secretions, prevent aspiration of gastric contents, and to control the airway for prolonged mechanical ventilation. METHOD: The hypothesis to improve the design of the tracheostomy tube, making it easier to use and eliminating most of the disadvantages found in prior tracheostomy tubes. RESULTS: This device is an improved tracheostomy tube designed with the balloon cuff (18), guide balloon (26), balloon connector (32) and guide balloon valve (24) located on the inner cannula (12). The major improvement in this tracheostomy tube is that the removal of the outer cannula will not be necessary when the balloon cuff is damaged, since replacing the inner cuffed cannula corrects the problem.

The invention relates to the field of immunological detection, in particular to a pepsase chemiluminescent immunoassay kit and a method thereof. The pepsase chemiluminescent immunoassay kit provided by the invention comprises: 1) a pepsase antigen calibrator; 2) sample collecting solution at a pH value of 2 to 3; 3) sample diluents at a pH value of 6 to 8; 4) a microporous plate coated by a pepsase antibody; 5) a pepsase antibody marker; 6) a chemical luminescence substrate liquid; and 7) concentrated cleaning solution. The kit provided by the invention can detect the pepsase content in gastric juice, esophageal content, throat secretion and tracheal bronchus secretion, judge if gastroesophageal reflux happens according to the result of the pepsase detection and judge the treatment effectof stomach diseases and change of state of illness according to the detected pepsase content. The kit has the advantages of noninvasiveness, simplicity, convenience, quickness, sensitivity, stabilityand the like.

Devices and methods for treating a diseased tracheobronchial region in a mammal. The device can be a stent which can include a sustained-release material such as a polymer matrix with a treatment agent. The stent can be bioabsorbable and a treatment agent can be incorporated therewith. A treatment method can be delivery of a stent to a tracheobronchial region by a delivery device such as a catheter assembly.

Devices and methods for treating a diseased tracheobronchial region in a mammal. The device can be a stent which can include a sustained-release material such as a polymer matrix with a treatment agent. The stent can be bioabsorbable and a treatment agent can be incorporated therewith. A treatment method can be delivery of a stent to a tracheobronchial region by a delivery device such as a catheter assembly.

The invention discloses a tracheal bronchus inner-diameter measuring ruler which comprises a handle sleeve, a first straight pipe, a strip-type groove, a sliding sleeve, a wire spool, a connecting block, a hose, a spring, a rotating strip, a first guide wire, a second straight pipe, a limit sleeve, a fixed frame, a fixed plate, a second guide wire, a through hole, a clamping block, a scale grooveand a rubber sleeve. The measuring ruler is reasonable in structure and novel in design, the opening distance of a near-end jaw can be calculated through the telescopic length of the first guide wire,so that the inner diameter of tracheal bronchus can be measured, accurate data are acquired, data of the narrow tracheal bronchus in different directions on the same horizontal plane can be acquired,the hose can be wound on the surface of the wire spool through the wire spool and a clamping block on the handle sleeve, and the tail end of the hose can be fixedly limited by the clamping block, sothat the whole measuring ruler is conveniently carried and stored and worthy of popularization and use.

The invention relates to a dry powder inhalant capable of preventing mycobacterium tuberculosis from transmitting through respiratory tract, and is capable of effectively solving a medical problem that mycobacterium tuberculosis infects pulmonary tuberculosis through the respiratory tract. The method comprises the following steps of: preparing the dry powder inhalant from 9.9-80% of an isoniazide sustained release microsphere, 19.9-90% of a rifampicin sustained release microsphere and 0.1-5% of a flow aid by weight percent, uniformly mixing the isoniazide sustained release microsphere, the rifampicin sustained release microsphere and the flow aid, packaging in gelatin or plastic capsules or aluminum-plastic bubble caps, or packaging in a multi-dosage dry powder inhalation device in the form of a reservoir, so as to obtain the dry powder inhalant. The dry powder inhalant disclosed by the invention is scientific and rational in formula, easy to produce and manufacture, good in use effect, and favorable for the powder to enter into pulmonary alveoli; the medicine is transmitted to and absorbed by the pulmonary alveoli to effectively kill and inhibit mycobacterium tuberculosis in trachea, bronchia and alveoli secretion of the respiratory tract, so as to reduce the quantity of floating droplets of patients of pulmonary tuberculosis removed in the surrounding environment, and to block the transmission of the mycobacterium tuberculosis in the public environment; and therefore, the dry powder inhalant has an important meaning for preventing the pulmonary tuberculosis.

Disclosed is a device for stimulating the tracheobronchial air of a patient suffering from an obstructive ventilatory disorder and able to modify the rheology of his tracheobronchial mucus, which includes a negative pressure generator, a physiological interface able to interface the device with the patient's respiratory apparatus, a connection pipe connecting the physiological interface to the negative pressure generator, and a control circuit capable of controlling the negative pressure generator, during the passive expiration phase, for the application of a succession of alternation of negative pressure and venting impulses with a determined frequency and a duty cycle determined during a first part of an expiration cycle and then a second frequency and a second duty cycle during a second part of the expiration cycle and to reiterate a defined number of expiration cycles.

The invention relates to an internal cooling microwave catheter capable of monitoring temperature in real time and a system. Aiming at tumors in the hollow organs including the bile duct, the esophagus, the colorectum, the sinuses ventriculi and the like, the invention provides a microwave catheter fixedly provided with an eccentric sacculus at the far end of a catheter body and a system, the eccentric sacculus and a microwave emission part are accurately placed at the position where the tumor of the lumen is located for treatment, aiming at primary hepatic carcinoma portal vein and vena cavacancer embolus, partial modification is made on the basis of the balloon catheter and the system, a hydrophilic super-lubricant guide wire capable of forming a loop at the far end of the catheter replaces the eccentric sacculus, and a microwave antenna and a thermocouple temperature probe are pushed for attaching to the cancer embolus in the vessel lumen or the tumor in the tracheal bronchus lumenfor treatment.

The invention discloses a fiber bronchoscope training box which comprises a box body, wherein the box body comprises an upper closed box body and a lower rectangular box body, the top of the box bodyis provided with a hole, the upper box body is in a tapered shape simulating the human body chest, the lower box body is provided with an opening which is provided with an openable door, a plurality of parallel partition boards are transversely arranged in the upper box body and the lower box body, the partition boards are provided with a plurality of through holes according to the tracheal bronchus structure, and the partition boards are movably or fixedly connected with the side wall of the box body. The invention has simple structure, low manufacture cost, strong operability and easy popularization and application, is scientific and reasonable in design because the through holes are arranged according to the corresponding positions of the tracheal bronchus under a living body fiber bronchoscope, and can achieve the purpose of promoting an operator to skillfully hold the human body tracheal bronchus structure.

The invention belongs to the technical field of food, and particularly relates to an almond tea drink capable of reducing haze harm and a preparing method thereof. The almond tea drink is prepared from dehulled apricot kernel, sticky rice, oat, lily, honeysuckle flower, fructo-oligosaccharide, tremella, dried rhizoma dioscoreae, licorice root, xylitol, stabilizer and water, raw material selection, baking and smashing, rehydration superfine grinding, blending and volume determination are conducted, the product is sent to a blending tank through a colloid mill, water is added into the blending tank, then homogenizing is conducted, homogenized drink pulp is sterilized through an ultra high temperature short time sterilization machine and cooled, and then filling is conducted. The almond tea drink has a long shelf life, is convenient to carry and can be drunk immediately after being opened. Although the almond tea drink can not directly act on haze particles, the almond tea drink can foster root and strengthen qi and can reduce the harm to lung by enhancing the immunity of lung; the formation of a mucous blanket on the tracheal epithelium is helped, and particle absorption and interception capacity is improved; tracheal bronchus cilium motility is improved, filtration and discharge of particles are helped, and then haze harm is reduced.

The invention belongs to the fields of medical instruments and tracheal bronchus disease interventional therapy, and particularly relates to a coverable medicine-carrying balloon expanding fully-biodegradable zinc alloy tracheal scaffold. According to the scaffold, bionic structure design is adopted, the scaffold is perfectly matched with a tracheal anatomical structure, and a covered or non-covered mode can be adopted for treating tracheal orificium fistulae or tracheal blocking. A tracheal scaffold base material is zinc alloy, and the zinc alloy has full degradation performance, so that secondary removal is avoided; through CT (computed tomography), the morphology of the trachea of the patient is obtained, then through data processing, a tracheal normal physiological anatomical structureis restored, anteroposterior diameter, mediolateral diameter, the height of C-type cartilage and the ligament height of the tracheal of the patient in a normal situation are measured, after data is obtained, a 3D printing technology is used for producing a tracheal scaffold prototype, and a laser engraving technology is used for forming microgrooves or micropores in the surface of the scaffold for medicine carrying so that granulation tissue proliferation can be inhibited.

The invention relates to a dilator, in particular to a dual-cavity capsule dilator with an electrocoagulation function, and belongs to the technical field of medical instruments. According to the technical scheme, the dual-cavity capsule dilator with the electrocoagulation function comprises a dilation capsule connecting body, a dilatation capsule body located at the dilatation capsule connectingbody and an electrocoagulation body which can be used for hemostasis and is adaptably connected with the dilation capsule connecting body, the electrocoagulation body comprises an electrocoagulation head and an electrocoagulation power supply connector adaptably connected with the electrocoagulation head, and the electrocoagulation head is located outside the head ends of the dilatation capsule body and the dilation capsule connecting body. The dual-cavity capsule dilator with the electrocoagulation function is compact in structure, convenient to use, safe and reliable, the narrow parts of trachea and bronchi can be effectively dilated, hemostasis operation can be achieved in the dilation process, required continuous dilation is achieved, the operation risk and difficulty are reduced, andthe efficiency of dilation operation is improved.

The invention provides a tracheal bronchus orificium fistula detecting device which mainly comprises a detection catheter, a balloon catheter, an occlusion balloon and a three-way connector. The three-way connector is connected with the tail end of the detection catheter and is connected with a carbon dioxide monitoring instrument, a connected syringe and the detection catheter, side openings are formed in the side walls of the head end of the detection catheter, the balloon catheter is used as an outer cannula for the detection catheter, a far end of the balloon catheter is connected with the occlusion balloon, and a hose connector at the tail end of the balloon catheter is communicated with the syringe and is used for blowing the balloon, so that local airways can be occluded. The tracheal bronchus orificium fistula detecting device has the advantages that the locations of orificium fistulae of tracheal bronchi can be accurately judged by the aid of difference of internal and external carbon dioxide concentration and measurement waveforms, and whether communication breather bronchi are available or not can be judged; the tracheal bronchus orificium fistula detecting device can be easily and feasibly operated and is excellent in peripheral bronchopleural fistula sensitivity, and the diagnosis rate and the cure rate of the orificium fistulae of the tracheal bronchi can be obviously increased; the tracheal bronchus orificium fistula detecting device is reasonable in design, simple in structure, convenient to operate, low in cost and high in efficiency.

The invention discloses a video tracheobronchial foreign body microscopic examination general anesthesia system. In the system, a microscopic examination anesthesia ventilation laryngotracheal microscope is a three-way special-shaped tube (1-5); the front end of the three-way special-shaped tube (1-5) serves as a video end outlet (1-6); an installation sliding telescopic tube (1-3) and a pipelineof a tracheobronchial microscope are arranged in the three-way special-shaped tube (1-5); and the outer side of one circle of the pipeline (1-1) is provided with a breathing air duct (2-10). According to the invention, an anesthesia breathing ventilation structure used for video anesthesia and extraction of microscopic examination foreign bodies, microscopic examination software programming and automatic storage and output of microscopic examination results are realized; a similar equipment system does not exist at home and abroad, and improved ventilation for an infant intratracheal foreign body microscope and general anesthesia are reported but are not perfect and reliable; and a microscopic examination anesthesia system for increasing the infant intratracheal foreign body curing rate and the survival rate, reducing damage caused by accidental suction of infants and improving the survival quality is needed.

Research finds that exocrine protein SCGB3A2 in lung tracheal bronchus is combined with a receptor PDPN on the cell surface and activates RhoA protein, so that the strength of pneumonia and the expression quantity of inflammatory factors are enhanced, and lung inflammation can be relieved and expression of inflammatory factors and infiltration of lung inflammatory cells can be reduced by blocking combination of SCGB3A2 and PDPN through an antibody. Therefore, the invention provides a brand new target for controlling lung inflammatory factor storm caused by bacteria or viruses. The target spot has a relatively clear signal transmission path, so that the side effect of the medicine for inhibiting the inflammatory factor storm, which is prepared aiming at the target spot, is smaller than that of glucocorticoid.

The invention relates to an oral tablet and a preparation method thereof. The oral tablet is mainly prepared from the following raw materials in parts by weight: 2-4 parts of coptis root leaf, 1-3 parts of honeysuckle, 1-3 parts of licorice, 1-3 parts of radix platycodi and 0.5-2 parts of peppermint. The oral tablet has good mouth feel and unique taste (a person feels sweet when the oral tablet enters the mouth, the person can feel both sweet taste and bitter taste after the oral tablet enters the mouth, weaker bitter taste still exists in the oral cavity even after the oral tablet is completely dissolved, and the person also feels coarse, fresh and cool when the oral tablet enters the mouth) and the oral tablet can be eaten as candy. Because of addition of the traditional Chinese medicines of the coptis root leaf and the like, the oral tablet has an obvious effect for ulceratiue stomatitis and throat gall which are caused by suffering from excessive internal heat and is combined withthe honeysuckle with the function of clearing away heat and toxic materials, the peppermint with the functions of dispelling wind heat and relieving sore-throat, the radix platycodi with the functions of promoting the dispersing function of the lung, relieving sore-throat and benefiting the voice and the licorice with the function of protecting the throat and the tracheal bronchus; the five medicines all serve as the raw materials, which can truly achieve the therapeutic effects of clearing and benefiting the throat.

The invention discloses an argy wormwood leaf volatile oil soft capsule for assisting treatment of bronchial asthma and a therapy by using the soft capsule. The soft capsule uses argy wormwood leaf volatile oil as a medicinal component, the argy wormwood leaf volatile oil is prepared in the form of a soft capsule dosage, an electronic heater is used as a drug delivery tool, the mechanical structure of the heater is used to destroy the soft capsule, the argy wormwood leaf volatile oil contained in the soft capsule is slowly released, the volatile oil is vaporized through the electrical heatingmanner and is inhaled into a respiratory tract through a mouth and nose, and medicinal molecules directly reach trachea, bronchus and lung and other lesions to realize quick positioning and play a role; the argy wormwood leaf volatile oil has antitussive antiasthmatic anti-inflammatory and antibacterial effects; and the therapy has an obvious quick-acting effect and positioning effect as a targeted drug delivery method, and can obviously relieve the symptom of the bronchial asthma, effectively reduce the dose of hormone drugs in traditional treatment, and reduce the side effects.

The present invention relates to a first-aid medicine for curing nitrogen oxide poisoning-an aerosol, its application and preparation method. Its raw material comprises beta 2 receptor excitant, anticholinergic, glucocorticoid hormone and mucusal protection agent, it can be effectively used for preventing and curing the chemical injury of larynx, trachea, bronchus, pulmonary alveoli, lymphatic vessel and blood vessel due to aspiration dinitrogen tetroxide and its harmful product poisoning, and can relieve or eliminate the diseases of exudate increment of respiratory system, bronchospasm, pneumonedema and respiratory dysfunction, etc. resulted from chemical pneumonia. Said invention aerosol also can be used for curing asthma.

We describe a Tracheal Tube insertion facilitator (“modified bougie”) with superior ventilating capability to enable medical / paramedical personnel to place tracheal / bronchial tubes reliably in trachea / bronchus of the patients under anaesthesia or patients in respiratory distress, and provide respiratory support. This device is particularly useful in situations where the conventional tracheal intubation technique using a laryngoscope is difficult or near impossible. This device has a outer cylindrical member, inner hollow stylet and a dynamic cuff which inflates during Positive Pressure Ventilation / Jet ventilation, and hence enabling oxygenation in patients with respiratory distress even before the tracheal tube is inserted into the patient's airway.

The invention discloses a thymus mongolicus essential oil soft capsule for treating bronchitis and a therapy of the thymus mongolicus essential oil soft capsule. Thymus mongolicus essential oil has relatively strong effects of inhibiting bacteria, resisting viruses, resisting inflammation, resisting allergy, relieving cough, reducing sputum and the like. According to the invention, the thymus mongolicus essential oil is used as a medicinal component to prepare the soft capsule, an electronic heater is used as an administration tool, a mechanical structure of the heater is used to damage the soft capsule, contained essential oil is slowly released, medicine molecules in the essential oil are vaporized in an electric heating manner, and the medicine molecules are inhaled into respiratory tracts through mouths and noses, so that the medicine molecules can deeply and directly reach lesion parts such as tracheas and bronchus to quickly play roles. As a directional administration mode, thetherapy has the advantages of obvious quick-acting effect and positioning effect, local administration, quick effect, small dosage and small toxic and side effects, has obvious curative effects on bronchitis treatment, cough relieving and sputum reduction, and can be used as an effective antibiotic replacement and antibiotic reduction treatment means.

The invention discloses a lung clearing and sputum excretion device. The device comprises a bottom plate and a bed plate; a vertical plate and a telescopic cylinder are arranged on the bottom plate; the bottom of the bed plate is hinged to the top of the vertical plate and the top of the telescopic cylinder; two shoulder baffles are mounted at the front part of the bed plate; a vertical frame is in threaded connection with the bottom plate; a motor and a piston cylinder are installed on the vertical frame; a rotary disc is in key connection with a power output shaft of the motor; an eccentricshaft is arranged on the rotary disc; a connecting rod is installed on the eccentric shaft; one end of the connecting rod is connected with a piston rod; the piston rod is sleeved by the piston cylinder; and a tapping block is fixedly connected to the bottom end of the piston rod. The bed has the advantages that the telescopic cylinder drives one end of the bed board to ascend or descend, so thatthe inclination angle of the bed board is adjusted, the upper body of a patient lying on the bed board inclines downwards, and sputum can be discharged from the body of the patient; the motor drives the rotary disc to rotate, and the connecting rod drives the piston rod to do piston motion in the piston cylinder in the vertical direction, so that the tapping block taps the back of the patient, andsecreta attached to the trachea, the bronchus and the lung is promoted to be loosened so as to be discharged conveniently.

The invention discloses a method for noninvasive screening of bronchial tuberculosis and an exhaled air segmented collection device. The method comprises the following steps: step 1, collecting exhaled air condensate specimens representing a large airway 0-2 seconds before atomization and exhaled air condensate specimens representing a small airway 3-10 seconds before atomization of a subject as a first group of exhaled air condensate specimens; 2, a subject inhales a tuberculosis specific secretory protein ESAT-6 + CFP-10 solution in an aerosol mode; 3, collecting exhaled air condensate specimens representing the large airway after the subject is atomized for 0-2 seconds and exhaled air condensate specimens representing the small airway after the subject is atomized for 3-10 seconds as a second group of exhaled air condensate specimens; and 4, detecting the content of gamma-interferon in the first group of exhaled air condensate samples and the second group of exhaled air condensate samples respectively, and screening according to the ratio of gamma-interferon after atomization and before atomization. The purpose of noninvasive screening of tracheal bronchial tuberculosis is achieved by detecting the change of gamma-interferon in exhaled air condensate in a segmented manner.

The invention discloses a video tracheobronchial foreign body microscopic examination general anesthesia system. In the system, a microscopic examination anesthesia ventilation laryngotracheal microscope is a three-way special-shaped tube (1-5); the front end of the three-way special-shaped tube (1-5) serves as a video end outlet (1-6); an installation sliding telescopic tube (1-3) and a pipeline of a tracheobronchial microscope are arranged in the three-way special-shaped tube (1-5); and the outer side of one circle of the pipeline (1-1) is provided with a breathing air duct (2-10). According to the invention, an anesthesia breathing ventilation structure used for video anesthesia and extraction of microscopic examination foreign bodies, microscopic examination software programming and automatic storage and output of microscopic examination results are realized; a similar equipment system does not exist at home and abroad, and improved ventilation for an infant intratracheal foreign body microscope and general anesthesia are reported but are not perfect and reliable; and a microscopic examination anesthesia system for increasing the infant intratracheal foreign body curing rate and the survival rate, reducing damage caused by accidental suction of infants and improving the survival quality is needed.

A tracheal sampling device is used to collect or acquire cells from an animal, such as at or near the tracheo-bronchial or larynx of an animal. The device includes a flexible and elongated shaft or stem, and a collection member at a distal end of the device. The collection member could be a swab or other member to best collect mucus. The device is used by inserting the collection end into an animal to position the collection member at or near the cell collection site, which may be in or around the larynx. The collection member is removed after collecting cells, which can be reviewed, tested, or otherwise managed to determine the presence of a disease or other bacteria. The length of the shaft or stem allows for optimal positioning of the swab in a variety of animal species and ages. The device can be disposed after each use.

The invention relates to an anesthesia technology for tracheal foreign body extraction, which has the difficulty that an anesthetist and a surgeon share one airway, so that sufficient oxygen supply for a child patient is ensured, and the stress reaction of the throat and the trachea to an embedded bronchoscope is inhibited to the greatest extent. Tracheal foreign matters mostly occur in infants under 3 years old, the illness state of sick children is critical, and foreign matters are taken out through an operation as a unique solution. However, the operation anesthesia risk is extremely high, bucking and breath holding are easily caused, oxygen deficit is caused by severe patients, and even sudden breathing and heartbeat arrest occurs. According to the anesthesia technology, by means of an oxygen supply mode that the bronchoscope is connected with the anesthesia machine, the problem that a surgeon and an anesthetist share the same airway is successfully solved. By means of sufficient and effective tracheal bronchus mucosa surface anesthesia, airway spasm is relieved, meanwhile, the dosage of intravenous anesthetics is reduced, autonomous respiration of the sick child is kept on the premise that the operation requirement is met, and the life safety of the sick child is guaranteed. The anesthesia technology has been successfully implemented in about 3000 sick children in our hospital from 2000 years, is safe and effective, and should be vigorously popularized, so that the life safety of more sick children is ensured.

The invention relates to the field of immunological detection, in particular to a pepsase chemiluminescent immunoassay kit and a method thereof. The pepsase chemiluminescent immunoassay kit provided by the invention comprises: 1) a pepsase antigen calibrator; 2) sample collecting solution at a pH value of 2 to 3; 3) sample diluents at a pH value of 6 to 8; 4) a microporous plate coated by a pepsase antibody; 5) a pepsase antibody marker; 6) a chemical luminescence substrate liquid; and 7) concentrated cleaning solution. The kit provided by the invention can detect the pepsase content in gastric juice, esophageal content, throat secretion and tracheal bronchus secretion, judge if gastroesophageal reflux happens according to the result of the pepsase detection and judge the treatment effect of stomach diseases and change of state of illness according to the detected pepsase content. The kit has the advantages of noninvasiveness, simplicity, convenience, quickness, sensitivity, stability and the like.

The invention relates to a dry powder inhaler capable of preventing respiratory transmission of Mycobacterium tuberculosis, which can effectively solve the drug problem of preventing and treating tuberculosis infection by Mycobacterium tuberculosis through the respiratory tract. %, rifampicin sustained-release microspheres 19.9-90%, glidant 0.1-5%, first mix isoniazid sustained-release microspheres, rifampicin sustained-release microspheres, and glidants together, Packed in gelatin, plastic capsules or aluminum-plastic blisters, or packaged in a multi-dose dry powder inhalation device in the form of a reservoir; the composition of the present invention is scientific, reasonable, easy to manufacture, good in use effect, and beneficial to powder The body enters the alveoli, and the drug is delivered to the alveoli to be absorbed. It is effectively used to kill and inhibit the Mycobacterium tuberculosis in the trachea, bronchi and alveolar secretions in the respiratory tract, and reduce the number of droplets with floating ability that tuberculosis patients exclude into the surrounding environment. To block the spread of Mycobacterium tuberculosis in the public environment is of great significance to the prevention of tuberculosis.

The invention discloses a bronchoscope robot guiding method and system. The method comprises the steps: S1, carrying out extraction of the three-dimensional map data and lesion position data of a tracheal bronchus according to the medical image data of the tracheal bronchus and the lungs of a patient; S2, according to an entrance point and a lesion position of the three-dimensional map data, creating an advancing route of a bronchoscope robot; S3, driving the bronchoscope robot to advance to the lesion position according to the advancing route by a magnetic field generator; and S41, acquiring an image in the advancing direction of the bronchoscope robot, judging whether the image is an obstacle or not, and if the image is the obstacle, driving the bronchoscope robot to bypass the obstacle to advance by the magnetic field generator. According to the technical scheme, the bronchoscope robot is configured to be in a capsule shape, enters from the nasal cavity or the oral cavity and is driven by the in-vitro magnetic field generator, glottis closing cannot be blocked, and the airway cannot be blocked.